Team:Concordia/Description

• 
• OUR TEAM
  • Team Members
  • Attributions
  • Contact Us
• PROJECT
  • Description
  • Lactococcus Lactis
  • Scaffold
  • Food Intolerances
  • Prototype Pathway
• RESULTS
  • Results of Cloning
  • Results of Testing
  • Future Work
• WET LAB
  • Notebook
• PARTS
  • Team Parts
• POLICIES
  • Human Practices
  • Outreach
  • Collaborations
  • Safety

“Every step of progress the world has made has been from scaffold to scaffold (...)”

Wendell Phillips

Project Description

Project Description

Project: Lactococcus scaffold

This year, our goal is to genetically engineer a strain of the species Lactococcus lactis to express an extracellular platform, which can bind to and anchor a very wide variety of enzymes. By introducing optimized genes from the bacterial species Clostridium thermocellum, we will be able to create a novel tool with seemingly endless possibilities.

By using the protein products of these optimized genes, we will be able to create an organized array of customizable enzymes that will bind to the cells' outer membrane.

Cohesins and Dockerins

The main gene products of interest in this work are known as Cohesins and Dockerins.

The Cohesins are structural proteins that form part of the outlay of the scaffold. These elements act as anchors for other proteins and are highly specific, which makes them reliable for the purpose of ordered display of proteins.

The Dockerins are also proteins and are usually fused with some other enzyme. These elements act as adaptors for the enzyme they are attached to, and allow them to anchor themselves onto the Cohesin elements of the scaffold.

There are different types of Cohesins, with their respective complementary Dockerins, which make the scaffold a very powerful tool in the biotechnology landscape.

Implications

• Increased efficiency

  For many metabolic processes happening in the cell, the enzymatic substrate must be imported into the cytoplasm for processing. This usually requires energy from the cell, which diminishes the efficiency of the process. In the same way, if the metabolic product of such a reaction would be of interest, the organism would require a way to excrete it, which is, again, energetically consuming. With an external scaffold holding these enzymes in place, the import of substrate and export of product would be bypassed, and therefore the efficiency of a certain enzymatic process could be increased or facilitated.

• Ordered multi-step processes

  By ordering the correct pairs of cohesins with their respective dockerin-enzyme fusion products on the scaffold, it is possible to recreate or engineer diverse multi-step processes with high efficiency. Imitating the naturally occurring process of enzyme channeling, emulating multi-enzyme complexes and programming seemingly complex metabolic processes are only some of the many possible advantages of the scaffold.

• Fusion of non-prokaryotic proteins to scaffold

  Many proteins that have potential scientific or industrial interest are difficult or impossible to express in prokaryotic organisms in a useful manner. Eukaryotic enzyme-dockerin fusion products could be expressed in some other organisms, like yeast, and displayed extracellularly on the bacterial scaffold, giving a whole new toolkit to researchers and companies alike.

Our proof of concept

To demonstrate the immediate practicality and usefulness of our project, we decided to tackle a health issue that affects an important number of people all over the world.

Lactose intolerance is the inability to degrade the sugar lactose normally, due to an insufficient secretion of the enzyme responsible for this process, known as lactase. This inability to break down lactose often results in symptoms of the gastrointestinal tract, such as feeling of discomfort, stomach pain, bloating and diarrhoea, which prevents the people suffering from this condition to consume dairy in which this sugar is found abundantly.

By introducing a combination of the scaffold-displaying strain of Lactococcus lactis, which is naturally found in dairy products such as yogurt and cheese, and a dockerin-lactase fusion product as a supplement for the gastrointestinal tract of patients suffering from this condition, significant and long-lasting relief could be offered along with the possibility of consuming dairy products regularly. This option is particularly attractive and represents a safe, reliable and longer-lasting alternative for the currently offered solutions for this problem.